FAKTOR OPTIONSSCHEIN - STRYKER CORP. Share Price

Certificat

DE000PC6SYK6

Market Closed - Deutsche Boerse AG 20:50:36 19/06/2024 BST
227.2 EUR +1.73% Intraday chart for FAKTOR OPTIONSSCHEIN - STRYKER CORP.
Current month+16.53%
1 month+21.35%
Date Price Change
19/06/24 227.2 +1.73%
18/06/24 223.3 +7.71%
17/06/24 207.3 -0.25%
14/06/24 207.8 +1.61%
13/06/24 204.5 -6.11%

Delayed Quote Deutsche Boerse AG

Last update June 19, 2024 at 08:50 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC6SYK
ISINDE000PC6SYK6
Date issued 16/06/2022
Strike 348.7 $
Maturity Unlimited
Parity 1 : 1
Emission price 100
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 335
Lowest since issue 59.09
Spread 24.6
Spread %9.51%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
348.7 USD
Average target price
372.9 USD
Spread / Average Target
+6.96%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW